John Andrew Partridge - EVP & Chief Commercial Officer, Turning Point Therapeutics, Inc

As of July 15, 2021


John Andrew Partridge Net Worth

  • Net worth is estimated to be at least $1.63M
  • Owns at least 21,767 units of Turning Point Therapeutics, Inc stock
  • Sold an estimated value of $139.99K in the last year at Turning Point Therapeutics, Inc

John Andrew Partridge Compensation at Turning Point Therapeutics, Inc in 2020

  • Earned a $220,758 salary
  • Rewarded $1,288,710 in stock value and options
  • Received a total compensation of $7,226,561

John Andrew Partridge Trading

  • Largest sale of shares was 1,869 units , worth over $139.99K on July 15, 2021
  • In total has made about 3 transactions over a year
  • Usually trades in July, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

John Andrew Partridge Mailing Address

  • Mailing address is C/o Centrexion Therapeutics Corporation 200 State Street Boston MA 02109 MA

Turning Point Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Athena Countouriotis, M.D. 2020 $580,000 - - $14,131,423 $539,400 $11,400 $15,262,223
Athena Countouriotis, M.D. 2018 $329,442 $400,000 $ $7,766,667 $158,971 $8,690 $8,663,770
Yi Larson 2020 $451,688 - - $1,434,883 $255,600 $114,716 $2,256,887
Yi Larson 2019 $158,523 $360,757 - $11,715,012 $283,500 $61,633 $12,579,425
Annette North 2020 $400,000 - - $2,434,953 $230,400 $11,400 $3,076,753
Annette North 2018 $ $ $ $ $ $ $
Andrew Partridge 2020 $220,758 - $1,288,710 $5,210,033 $304,560 $202,500 $7,226,561
Andrew Partridge 2018 $ $ $ $ $ $ $
Siegfried Reich, Ph.D. 2020 $325,000 - - $5,227,485 $187,097 - $5,739,582
Siegfried Reich, Ph.D. 2018 $ $ $ $ $ $ $
Jingrong Jean Cui, Ph.D. 2020 $43,217 - - $1,870,156 - $1,189,061 $3,102,434
Jingrong Jean Cui, Ph.D. 2018 $399,289 $ $ $11,715,012 $283,500 $3,674 $12,401,475
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1595893/000119312521117723/d27986ddef14a.htm

Turning Point Therapeutics, Inc Insider Trading

  • The most recent transaction was 10,000 units sold on August 31, 2021 by Annette North worth over $800K
  • In the last 2 years, insiders at Turning Point Therapeutics, Inc sold an estimated value of $71.63M and bought an estimated value of $66.53M
  • The most active traders are Jean Jingrong Cui, Director,  Annette North, EVP,  and Athena Countouriotis, President & CEO
  • Insider trading is most common in June, with the busiest year in 2020

Turning Point Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1